A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-39758979 in Adult Japanese Subjects With Moderate Atopic Dermatitis
Latest Information Update: 04 Dec 2015
At a glance
- Drugs JNJ 39758979 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
Most Recent Events
- 27 Nov 2014 New trial record